Improved quality of life with effective Treatment of Facial Melasma: the PIGMENT trial

Journal of Drugs in Dermatology, July-August, 2004 by R. Balkrishnan, A.P. Kelly, A. Mcmichael, H. Torok

References

1. Pandya AG, Guevara IL. Disorders of Hyperpigmentation. Dermatol Clin 2000; 18:91-98.

2. Grimes PE. Melasma: Etiologic and Therapeutic Considerations. Arch Dermatol 1995: 131:1453-1457.

3. Katsambas A. Antoniou C. Melasma: Classification and Treatment. J Eur Acad Dermatol Venereol 1995; 4:217-223.

4. Kauh YC, Zachian TF. Melasma. Adv Exp Med Biol 1999; 455:491-499.

5. Balkrishnan R, et al. Predictors of Health-related Quality of Life in Women with Melasma. Cosmetic Dermatol 2003; 16:25-30.

6. Stulberg DL, Clark N. Common Hyperpigmentation Disorders in Adults: Part II. Melanoma, Seborrheic Keratoses. Acanthosis Nigricans, Melasma, Diabetic Dermopathy, Tinea Versicolor, and Postinflammatory Hyperpigmentation. Am Fam Phys 2003; 68:1963-1968.

7. Anderson RT, Rajagopalan R. Development and Validation of a Quality of Life Instrument for Cutaneous Diseases. J Am Acad Dermatol 1997; 37:41-50.

8. Chren MM, et al. Measurement Properties of SKINDEX-16: A Brief Quality-of-Life Measure for Patients with Skin Diseases. J Cutan Med Surg 2000; 5:105-110.

9. Data on file, Galderma Laboratories, L.P., Fort Worth, Texas.

10. Hurley ME, et al. Efficacy of Glycolic Acid Peels in the Treatment of Melasma. Arch Dermatol 2002; 138:1578-1582.

11. Rendon MI. Melasma and Postinflammatory Hyper pigmentation. Cosmetic Dermatol 2003; 16(suppl 3):9-17.

12. Gano SE, Garcia RL. Topical Tretinoin, Hydroquinone, and Betamethasone Valerate in the Therapy of Melasma. Cutis 1979; 23:239-241.

13. Giannotti B, Melli MC. Current Approaches to the Treatment of Melasma. Clin Drug Invest 1995; 10(suppl 2):57-64.

14. Griffiths CEM, et al. Topical Tretinoin (Retinoic Acid) Improves Melasma. A Vehicle-Controlled, Clinical Trial. Br J Dermatol 1993; 129:415-421.

15. Guevara IL. Pandya AG. Melasma Treated with Hydroquinone, Tretinoin, and a Fluorinated Steroid. Int J Dermatol 2001; 40:212-215.

16. Kang WH, Chun SC, Lee S. Intermittent Therapy for Melasma in Asian Patients with Combined Topical Agents (Retinoic Acid, Hydroquinone, and Hydrocortisone): Clinical and Histological Studies. J Dermatol 1998; 25:587-596.

17. Kimbrough-Green CK, et al. Topical Retinoic Acid (Tretinoin) for Melasma in Black Patients. Arch Dermatol 1994; 130:727-733.

18. Kligman AM, Willis I. A New Formula for Depigmenting Human Skin. Arch Dermatol 1975; 111:40-48.

19. Sarkar R. Bhalla M, Kanwar AJ. A Comparative Study of 20% Azelaic Acid Cream Monotherapy Versus a Sequential Therapy in the Treatment of Melasma in Dark Skinned Patients. Dermatology 2002; 205:249-254.

20. Sarkar R, et al. The Combination of Glycolic Acid Peels with a Topical Regimen in the Treatment of Melasma in Dark-skinned Patients: A Comparative Study. Dermatol Surg 2002; 28:828-832.

21. Sanchez JL. Vazquez M. A Hydroquinone Solution in the Treatment of Melasma. Int J Dermatol 1982; 20:55-58.

22. Verallo-Rowell VM, et al. Double-blind Comparison of Azelaic Acid and Hydroquinone in the Treatment of Melasma. Acta Derm Venereol 1989; 143(suppl):58-61.

23. Taylor SC, et al. Efficacy and Safety of a New Triple-combination Agent for the Treatment of Facial Melasma. Cutis 2003; 72:67-72.